Fund Holdings — EcoR1 Capital, LLC

Total Portfolio Value:
$1.69B
Total Bought:
$282.26M
Total Sold:
$279.67M
Net Transaction:
+$2.60M
Notable People:
Scott Eric Perlen
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Zymeworks Inc.(ZYME)17,259,54822,970,388+5,710,840$205.56M$288.28M17.08%+$82.72M
Apellis Pharmaceuticals Inc
COM
11,895,80811,895,8080$260.16M$205.92M12.20%-$54.24M
Jazz Pharmaceuticals plcSHS USD(JAZZ)1,706,4691,706,4690$211.86M$181.09M10.73%-$30.77M
Anaptysbio Inc7,880,0947,880,0940$146.49M$174.94M10.37%+$28.45M
Crinetics Pharmaceuticals In4,288,1204,288,1200$143.82M$123.33M7.31%-$20.50M
Iteos Therapeutics Inc010,688,978+10,688,978$0$106.57M6.32%+$106.57M
CRISPR Therapeutics AGNAMEN AKT(CRSP)1,389,2761,389,2760$47.28M$67.57M4.00%+$20.30M
uniQure N.V.SHS(QURE)3,988,9713,988,9710$42.28M$55.61M3.30%+$13.32M
Tango Therapeutics, Inc.(TNGX)10,630,73610,630,7360$14.56M$54.43M3.23%+$39.87M
Xencor, Inc.(XNCR)6,144,7676,144,7670$65.38M$48.30M2.86%-$17.08M
Immunome, Inc.(IMNM)4,079,4154,079,4150$27.45M$37.94M2.25%+$10.48M
Janux Therapeutics, Inc.(JANX)1,469,8181,469,8180$39.69M$33.95M2.01%-$5.73M
Lakefront Biotherapeutics NVADR(LKFT)155,0061,036,945+881,939$3.89M$29.02M1.72%+$25.13M
Eton Pharmaceuticals, Inc.(ETON)1,939,2882,030,544+91,256$25.17M$28.94M1.71%+$3.76M
Kura Oncology, Inc.(KURA)2,640,2984,200,000+1,559,702$17.43M$24.23M1.44%+$6.81M
Akero Therapeutics Inc440,000440,0000$17.81M$23.48M1.39%+$5.67M
Madrigal Pharmaceuticals, Inc.(MDGL)75,00075,0000$24.84M$22.70M1.35%-$2.14M
Neurogene Inc.(NGNE)1,271,3421,271,3420$14.89M$19.01M1.13%+$4.12M
Verona Pharma PlcADS0200,000+200,000$0$18.92M1.12%+$18.92M
Tectonic Therapeutic, Inc.(TECX)935,121935,1210$16.56M$18.58M1.10%+$2.02M
ORIC Pharmaceuticals, Inc.(ORIC)3,418,0681,618,068-1,800,000$19.07M$16.42M0.97%-$2.65M
Alkermes plcSHS(ALKS)0500,000+500,000$0$14.30M0.85%+$14.30M
Avidity Biosciences Inc557,576500,000-57,576$16.46M$14.20M0.84%-$2.26M
MBX Biosciences, Inc.(MBX)1,259,2731,149,794-109,479$9.29M$13.12M0.78%+$3.83M
Voyager Therapeutics, Inc.(VYGR)3,917,5463,917,5460$13.24M$12.18M0.72%-$1.06M
Pacira BioSciences, Inc.(PCRX)0457,471+457,471$0$10.93M0.65%+$10.93M
Replimune Group, Inc.(REPL)850,341850,3410$8.29M$7.90M0.47%-$391.2K
Metsera Inc50,000271,529+221,529$1.36M$7.72M0.46%+$6.36M
Adaptimmune Therapeutics plcADS(ADAPY)27,404,07027,404,0700$5.40M$6.57M0.39%+$1.17M
Day One Biopharmaceuticals I
COM
862,068862,0680$6.84M$5.60M0.33%-$1.23M
Hillevax Inc02,420,243+2,420,243$0$4.82M0.29%+$4.82M
Atara Biotherapeutics Inc573,183573,1830$3.40M$4.42M0.26%+$1.02M
Whitehawk Therapeutics, Inc.(WHWK)2,082,0001,091,417-990,583$3.71M$2.04M0.12%-$1.67M
MacroGenics, Inc.(MGNX)01,602,717+1,602,717$0$1.94M0.11%+$1.94M
Nuvation Bio Inc.W EXP 02 10 202(NUVB)963,333963,3330$1.70M$1.88M0.11%+$183.0K
Surrozen, Inc.W EXP 08 01 203(SRZN)66,66566,6650$777.3K$596.0K0.04%-$181.3K
Aligos Therapeutics, Inc.(ALGS)88,5690-88,569$730.7K$0—-$730.7K
Beam Therapeutics Inc.(BEAM)526,6850-526,685$10.29M$0—-$10.29M
Bicycle Therapeutics PlcADS910,0000-910,000$7.73M$0—-$7.73M
Ginkgo Bioworks Holdings, Inc.CL A(DNA)1,462,3280-1,462,328$8.34M$0—-$8.34M
Kalaris Therapeutics, Inc.(KLRS)201,7180-201,718$1.62M$0—-$1.62M
Keros Therapeutics, Inc.(KROS)187,5000-187,500$1.91M$0—-$1.91M
Prime Medicine, Inc.(PRME)700,0000-700,000$1.39M$0—-$1.39M
Prothena Corp PlcSHS
SHS
11,584,2800-11,584,280$143.36M$0—-$143.36M
Relay Therapeutics, Inc.(RLAY)641,4260-641,426$1.68M$0—-$1.68M
Sarepta Therapeutics, Inc.(SRPT)1,292,3860-1,292,386$82.48M$0—-$82.48M
Solid Biosciences Inc744,4500-744,450$2.75M$0—-$2.75M
TScan Therapeutics, Inc.(TCRX)662,8330-662,833$914.7K$0—-$914.7K
Upstream Bio, Inc.(UPB)60,0000-60,000$367.2K$0—-$367.2K
Verve Therapeutics Inc1,250,0000-1,250,000$5.71M$0—-$5.71M
Page 1 of 1
EcoR1 Capital, LLC — 13F Holdings — Q2 2025 | TickerTrail